MedTrace Logo

Behçet's Disease and Eosinophil Cationic Protein

NCT01584778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2012-04-26

No results posted yet for this study

Summary

Eosinophil cationic protein (ECP) is a matrix protein of eosinophils and has been reported to reflect eosinophil activity. Few studies have examined the role of eosinophils in the pathogenesis of Behçet's disease. The purpose of the present study is to investigate the serum ECP levels in BD and its relation to clinical activity.

Conditions

  • Behçet's Disease

Interventions

OTHER

eosinophil cationic protein

Serum eosinophil cationic protein levels

Sponsors & Collaborators

  • Cukurova University

    lead OTHER

Principal Investigators

  • Hüseyin TE Ozer, Assoc. Prof. · Cukurova University, Faculty of Medicine, Rheumatology-Immunology Department

  • Eren Erken, Prof. Dr. · Cukurova University, Faculty of Medicine, Rheumatology-Immunology Department

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2002-12-31
Completion
2002-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01584778 on ClinicalTrials.gov